Pradžia › Aplastinė anemija › Merilendas
Aplastinė anemija klinikiniai tyrimai Merilendas
10 tyrimai dėl Aplastinė anemija ieško dalyvių vietose Merilendas.
Miestai Merilendas
Oficialus tyrimo tekstas (anglų kalba)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1/2 fazė
Amžius nuo 4 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT03173937Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 2 iki 99 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05012111Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
1 Day – 100 Years · Visoms lytims · Atnaujinta 2026-09-30 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai2 fazė
Amžius nuo 4 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT01174108Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai2 fazė
Amžius nuo 4 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT03520647A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai2 fazė
Amžius nuo 3 iki 99 · Visoms lytims · Atnaujinta 2026-03-09 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
Renkami dalyviai2 fazė
Amžius nuo 3 iki 75 · Visoms lytims · Atnaujinta 2026-02-17 · NCT06517641Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.